These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8020035)

  • 1. [Treatment of hyperlipidemia in patients with ischemic heart disease].
    Pauciullo P; Lirato C; Sapio C; Mancini M
    Cardiologia; 1993 Dec; 38(12 Suppl 1):345-8. PubMed ID: 8020035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipids and acute coronary syndromes].
    Stejfa M
    Vnitr Lek; 2000 Sep; 46(9):520-5. PubMed ID: 11344644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease].
    Ose L
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3629-31. PubMed ID: 8539720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and an update on trials now in progress.
    Ericsson CG
    Eur Heart J; 1998 Jul; 19 Suppl H():H37-41. PubMed ID: 9717064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyslipidemia in the elderly].
    Lasses y Ojeda LA; Gutiérrez JL; Salazar E
    Arch Cardiol Mex; 2004; 74(4):315-26. PubMed ID: 15709510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will serum lipid lowering treatment reduce the incidence of coronary heart disease?
    Vessby B; Lithell H; Boberg J
    Artery; 1981; 9(5):372-81. PubMed ID: 7032466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH; Huijberts MS
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary and secondary prevention of atherosclerotic disease by lipid-lowering therapies].
    Mabuchi H
    Nihon Rinsho; 1999 Dec; 57(12):2807-14. PubMed ID: 10638217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.
    Verri V; Cunha AB; Tessarolo LE; Carneiro RC; Romêo Filho LJ
    Rev Port Cardiol; 2004 Sep; 23(9):1089-105. PubMed ID: 15587571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of long-term Enduracin monotherapy on the clinical and biochemical status of patients with ischemic heart disease].
    Kukharchuk VV; Solov'ev EIu; Malyshev PP; Rozhkova TA; Semenova OA; Aronskaia EE
    Ter Arkh; 1997; 69(9):41-5. PubMed ID: 9411824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of lipid lowering measures on coronary perfusion].
    Steinmetz A; Maisch B; Noll B
    Z Kardiol; 1997; 86 Suppl 1():43-55. PubMed ID: 9173721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pharmacologic research on "shen yang formulae"].
    Zhen Y; Liang S
    Zhong Yao Cai; 1998 Aug; 21(8):411-4. PubMed ID: 12569849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.